Emcure Pharmaceuticals Limited is a leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynaecology and HIV antiviral therapeutic areas for the MAT September 2023.
In the six months ended September 30, 2023, and the Financial Year 2023, sales in India contributed 50.84% and 53.16% of the company’s total revenue, respectively. The company’s Domestic sales grew at a CAGR of 10.80% between September 2019 and September 2023, outperforming the Indian pharmaceutical market.
As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files.
Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients such as chiral molecules, iron molecules, and cytotoxic substances.
As of September 30, 2023, the company’s marketing and distribution network in India was supported by over 5,000 field personnel who regularly interacted with healthcare providers. The distribution network included over 5,000 stockists, served by 37 carry-and-forward agents.
Emcure Pharmaceuticals IPO – Details
| IPO Opening Date | 03 July 2024 |
| IPO Closing Date | 05 July 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: [] Shares Worth ₹[] Crore Fresh Issue: [] Shares Worth ₹800.00 Crore Offer For Sale: 1,14,28,839 Shares Worth ₹[] Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹[] – ₹[] per share |
| Market Lot | – |
| Min Order | – |
| Listing At | BSE, NSE |
| Register | Link Intime India Private Ltd |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Emcure Pharmaceuticals IPO – Date Schedule
| IPO Open Date | 03 July 2024 |
| IPO Close Date | 05 July 2024 |
| Credit of Shares to Demat Account | 08 July 2024 |
| Initiation of Refund | 09 July 2024 |
| Credit of Shares to Demat Account | 09 July 2024 |
| IPO Listing Date | 10 July 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 05, 2024 |
Emcure Pharmaceuticals IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | – | – | ₹ |
| Retail (Max) | – | – | ₹ |
| S-HNI (Min) | – | – | ₹ |
| S-HNI (Max) | – | – | ₹ |
| B-HNI (Min) | – | – | ₹ |
Competitive Strengths
- Well-placed to leverage our position in the domestic market.
- Demonstrated capabilities of building brands.
- Large, diversified and fast-growing product portfolio in international markets.
- Strong R&D capabilities driving differentiated portfolio of products.
- Extensive and diversified manufacturing capacity.
- Highly qualified, experienced and entrepreneurial management team and Board.
Company Promoters
- Satish Ramanlal Mehta
- Sunil Rajanikant Mehta
- Namita Vikas Thapar
- Samit Satish Mehta
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2022 | 5918.86 | 4946.31 | 702.55 | 2102.19 |
| 31 March 2023 | 6031.71 | 5278.35 | 561.84 | 2202.42 |
| 31 March 2024 | 6715.24 | 5978.08 | 527.57 | 2091.93 |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | – |
| ROCE | – |
| Debt/Equity | – |
| RoNW | – |
| P/BV | – |
| PAT Margin (%) | – |
| Pre IPO | Post IPO | |
| EPS (Rs) | – | – |
| P/E (x) | – | – |
Objects Of The Issue
- Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company; and
- General corporate purposes
Emcure Pharmaceuticals IPO Peer Comparison
| S. No. | Face Value | Company Name | PE |
| 1 | 10 | Abbott India Limited | 47.43 |
| 2 | 2 | Alkem Laboratories Limited | 33.86 |
| 3 | 1 | J. B. Chemicals & Pharmaceuticals Limited | 50.49 |
| 4 | 2 | Cipla Limited | 30.10 |
| 5 | 5 | Dr. Reddy’s Laboratories Limited | 17.93 |
| 6 | 5 | Torrent Pharmaceuticals Limited | 57.74 |
| 7 | 1 | Mankind Pharma Limited | 45.30 |
Emcure Pharmaceuticals IPO Promoter Holding
| Pre Issue Share Holding | 98.88% |
| Post Issue Share Holding |
Emcure Pharmaceuticals IPO Prospectus
- Emcure Pharmaceuticals IPO DRHP
- Emcure Pharmaceuticals IPO RHP
Company Contact Information
| Emcure Pharmaceuticals Limited Emcure House, T-184, M.I.D.C., Bhosari, Pune – 411 026, Maharashtra, India. Tel: +(91) 20 35010000/ 40700000 E-mail: investors@emcure.co.in Website: https://www.emcure.com/ |
Emcure Pharmaceuticals IPO Registrar
| Link Intime India Private Limited C-101, 1st Floor, 247 Park L.B.S. Marg, Vikhroli West, Mumbai 400 083 Maharashtra, India Tel: +91 22 4918 6200 E-mail: emcurepharma.ipo@linkintime.co.in Website: https://www.linkintime.co.in/ |
Emcure Pharmaceuticals IPO Lead Manager(s)
| 1. Axis Capital Limited 2. BofA Securities India Limited 3. Credit Suisse Securities (India) Private Limited 4. JM Financial Limited 5. BOB Capital Markets Limited |
Emcure Pharmaceuticals IPO FAQs
| When Emcure Pharmaceuticals IPO will open? The Emcure Pharmaceuticals IPO dates are March 2022 To March 2022. |
| What is the lot size of Emcure Pharmaceuticals IPO? Emcure Pharmaceuticals IPO lot size is [] and total amount is []. |
| How to apply for Emcure Pharmaceuticals IPO? You can apply in Emcure Pharmaceuticals IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. |
| When is Emcure Pharmaceuticals IPO listing date? The Emcure Pharmaceuticals IPO listing date is announced. The date of Emcure Pharmaceuticals IPO listing is []. |
